CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice.

Weber, C J; Hagler, M K; Chryssochoos, J T; Kapp, J A; Korbutt, G S; Rajotte, R V; Linsley, P S

Weber, C J; Hagler, M K; Chryssochoos, J T; Kapp, J A; Korbutt, G S; Rajotte, R V; Linsley, P S.

Affiliation

Weber CJ; Department of Surgery, Bristol Myers-Squibb, Seattle, WA, USA.

Cell Transplant ; 6(5): 505-8, 1997.

Article in En | MEDLINE | ID: mdl-9331502

Subject(s)

Antigens, Differentiation/therapeutic use; Diabetes Mellitus, Type 1/surgery; Immunoconjugates; Immunosuppressive Agents/therapeutic use; Islets of Langerhans Transplantation/methods; Abatacept; Animals; Animals, Newborn; Antigens, CD; CTLA-4 Antigen; Cell Survival; Cells, Cultured; Diabetes Mellitus, Type 1/drug therapy; Drug Compounding; Insulin/metabolism; Insulin Secretion; Mice; Mice, Inbred NOD; Peritoneal Cavity/cytology; Recombinant Fusion Proteins; Swine; Transplantation, Heterologous

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antigens, Differentiation / Islets of Langerhans Transplantation / Immunoconjugates / Diabetes Mellitus, Type 1 / Immunosuppressive Agents Limits: Animals Language: En Journal: Cell Transplant Year: 1997 Document type: Article

Search on Google

XML

PubMed Links